# Aptevo Therapeutics Inc.: filings

APVO · Nasdaq · CIK 1671584 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/apvo.md) · [Financials](/companies/apvo/financials.md) · [Filings](/companies/apvo/filings.md) · [Insiders](/companies/apvo/insiders.md)

## Reports and events: 254 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 232, 8-K 166, CORRESP 37, 10-Q 31, 3 25, UPLOAD 22, SC 13G/A 20, EFFECT 17, DEF 14A 16, SC 13G 13, SCHEDULE 13G 13, 424B4 12, 424B5 11, S-1 11, 10-K 10, DEFA14A 9, PRE 14A 9, S-1/A 9, SCHEDULE 13G/A 9, S-3 8, S-8 7, 4/A 6, SC 13D/A 5, 10-12B/A 4, ARS 4, DEFR14A 3, 10-K/A 2, CT ORDER 2, D 2, RW 2, SC 13D 2, SC TO-I/A 2, 10-12B 1, 10-Q/A 1, 424B3 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, DEFC14A 1, DFAN14A 1, DRS 1, PREC14A 1, S-1MEF 1, S-3/A 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 08:13 ET | [8-K](/filings/0001193125-26-431079.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-431079 |
| 2026-10-23 | 16:05 ET | [8-K](/filings/0001193125-26-430419.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-26-430419 |
| 2026-10-14 | 08:52 ET | [8-K](/filings/0001193125-26-421076.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-421076 |
| 2026-09-24 | 08:10 ET | [8-K](/filings/0001193125-26-400213.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-400213 |
| 2026-09-23 | 16:43 ET | [8-K](/filings/0001193125-26-399545.md) | 5.07 Shareholder vote results | 0001193125-26-399545 |
| 2026-09-03 | 08:15 ET | [8-K](/filings/0001193125-26-381098.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-381098 |
| 2026-08-31 | 17:29 ET | [DEF 14A](/filings/0001193125-26-376763.md) | Proxy statement, period 2026-09-22 | 0001193125-26-376763 |
| 2026-08-21 | 16:10 ET | [S-1](/filings/0001193125-26-361103.md) | Registration statement | 0001193125-26-361103 |
| 2026-08-21 | 16:05 ET | [8-K](/filings/0001193125-26-361079.md) | 5.07 Shareholder vote results | 0001193125-26-361079 |
| 2026-08-14 | 08:15 ET | [10-Q](/filings/0001193125-26-350559.md) | Quarterly report, period 2026-06-30 | 0001193125-26-350559 |
| 2026-08-14 | 08:10 ET | [8-K](/filings/0001193125-26-350537.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-350537 |
| 2026-08-13 | 16:37 ET | [8-K](/filings/0001193125-26-349380.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-349380 |
| 2026-07-31 | 16:15 ET | [DEF 14A](/filings/0001193125-26-328604.md) | Proxy statement, period 2026-07-31 | 0001193125-26-328604 |
| 2026-07-27 | 16:05 ET | [8-K](/filings/0001193125-26-318056.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-318056 |
| 2026-06-30 | 16:05 ET | [8-K](/filings/0001193125-26-290473.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-290473 |
| 2026-05-27 | 16:05 ET | [8-K](/filings/0001193125-26-241867.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-241867 |
| 2026-05-13 | 16:15 ET | [10-Q](/filings/0001193125-26-221661.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221661 |
| 2026-05-13 | 16:05 ET | [8-K](/filings/0001193125-26-221593.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-221593 |
| 2026-05-06 | 16:08 ET | [8-K](/filings/0001193125-26-208958.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-208958 |
| 2026-03-26 | 16:15 ET | [10-K](/filings/0001193125-26-126278.md) | Annual report, period 2025-12-31 | 0001193125-26-126278 |
| 2026-03-26 | 16:05 ET | [8-K](/filings/0001193125-26-126190.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126190 |
| 2026-03-11 | 17:59 ET | [8-K](/filings/0001193125-26-100539.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-100539 |
| 2026-02-19 | 19:24 ET | [8-K](/filings/0001193125-26-057707.md) | 5.07 Shareholder vote results | 0001193125-26-057707 |
| 2026-02-03 | 08:15 ET | [8-K](/filings/0001193125-26-034473.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-034473 |
| 2026-01-28 | 16:05 ET | [S-1](/filings/0001193125-26-027200.md) | Registration statement | 0001193125-26-027200 |
| 2026-01-26 | 16:05 ET | [DEF 14A](/filings/0001193125-26-022560.md) | Proxy statement, period 2026-01-23 | 0001193125-26-022560 |
| 2026-01-09 | 08:17 ET | [8-K](/filings/0001193125-26-008318.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-008318 |
| 2025-12-29 | 17:05 ET | [8-K](/filings/0001193125-25-335497.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-335497 |
| 2025-12-09 | 17:23 ET | [8-K](/filings/0001193125-25-312972.md) | 9.01 Financial statements and exhibits | 0001193125-25-312972 |
| 2025-11-06 | 16:18 ET | [10-Q](/filings/0001193125-25-269598.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269598 |
| 2025-11-06 | 16:06 ET | [8-K](/filings/0001193125-25-269470.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269470 |
| 2025-10-30 | 16:30 ET | [8-K](/filings/0001193125-25-258665.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-258665 |
| 2025-10-01 | 16:30 ET | [S-1](/filings/0001193125-25-226825.md) | Registration statement | 0001193125-25-226825 |
| 2025-09-16 | 17:07 ET | [8-K](/filings/0001193125-25-205107.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-205107 |
| 2025-09-04 | 16:19 ET | [8-K](/filings/0001671584-25-000005.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001671584-25-000005 |
| 2025-08-11 | 08:12 ET | [10-Q](/filings/0000950170-25-106247.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106247 |
| 2025-08-11 | 08:11 ET | [8-K](/filings/0000950170-25-106246.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106246 |
| 2025-07-25 | 16:15 ET | [S-1](/filings/0000950170-25-098788.md) | Registration statement | 0000950170-25-098788 |
| 2025-07-24 | 17:28 ET | [8-K](/filings/0000950170-25-098429.md) | 5.07 Shareholder vote results | 0000950170-25-098429 |
| 2025-07-03 | 12:11 ET | [DEF 14A](/filings/0000950170-25-093924.md) | Proxy statement, period 2025-07-24 | 0000950170-25-093924 |
| 2025-07-01 | 17:05 ET | [8-K](/filings/0000950170-25-092318.md) | 8.01 Other events | 0000950170-25-092318 |
| 2025-06-30 | 16:15 ET | [8-K](/filings/0000950170-25-091581.md) | 8.01 Other events | 0000950170-25-091581 |
| 2025-06-23 | 16:05 ET | [8-K](/filings/0000950170-25-088970.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-088970 |
| 2025-06-20 | 17:21 ET | [8-K](/filings/0000950170-25-088592.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088592 |
| 2025-06-20 | 16:05 ET | [8-K](/filings/0000950170-25-088494.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088494 |
| 2025-06-17 | 16:15 ET | [8-K](/filings/0000950170-25-087368.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-087368 |
| 2025-06-16 | 08:15 ET | [S-1](/filings/0000950170-25-086548.md) | Registration statement | 0000950170-25-086548 |
| 2025-05-23 | 17:10 ET | [8-K](/filings/0000950170-25-077089.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-077089 |
| 2025-05-22 | 17:29 ET | [8-K](/filings/0000950170-25-076482.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-076482 |
| 2025-05-15 | 16:10 ET | [10-Q](/filings/0000950170-25-072622.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072622 |

Page 1 of 6. [Older](/companies/apvo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:45 ET. No prices; not investment advice.